BNP Paribas Financial Markets
MANE

BNP Paribas Financial Markets’s Veradermics Inc MANE Stock Holding History

BNP Paribas Financial Markets’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Buy
+3,200
New +$300K ﹤0.01% 3887

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's MANE Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Veradermics Inc (MANE) in Q2 2026: 3,200 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #3887 among its holdings.

93 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • BNP Paribas Financial Markets held 3,200 shares of Veradermics Inc worth $393K as of Q2 2026.
  • Veradermics Inc was a new BNP Paribas Financial Markets position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3887 holding.
  • 93 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.